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Abstract 
Calcium pyrophosphate dihydrate (CPPD) crystal 
deposition disease is characterized by depo sits of triclinic (t) 
and monoclinic (m) CPPD crystals in articular and 
fibrocartilage. Many investigators have attempted to model 
CPPD crystal growth using both solution and a variety of gel 
systems. We have investigated the effect of type I collagen 
fibrils on CPPD crystal nucleation and growth using an ionic 
diffusion model. Collagen was isolated from porcine menisci 
using a pepsin solubilization procedure and gelled in three 
layers, with one containing JO mM pyrophosphate (PPi) plus 
physiologic ions, the middle containing only the ions, while 
the third contained 25 mM Ca plus physiologic ions. 
Initially , amorphorous calcium pyrophosphate formed at the 
Ca-PPi interface . Monoclinic CPPD crystallized in 6 weeks 
when the [Ca] was between 2 and 3 mM and the [PPiJ was 
between 50 and 75 µM . At 13 weeks, t-CPPD formed when 
the [Ca] was also between 2 and 3 mM, but the PPi was less 
than 25 µM. One of the most striking differences between 
this system and all previous solution and gel model systems 
is the total absence of orthorhombic calcium pyrophosphate 
tetrahydrate (o-CPP1) from the gels made of collagen fibrils 
in near native conformation . Further, crystals of t-CPPD 
appear as large single crystals with the classic prismatic 
growth habit observed in vivo, and crystals of m-CPPD also 
evidence the in vivo rod habit. 1n contrast, the crystal growth 
habits of t-CPPD, m-CPPD, and o-CPPT grown in all of the 
other model systems never matched that observed in vivo. 
When compared to the previous studies, these results, 
particularly the crystal growth habit data, suggest that the 
native collagen fibrils themselves can nucleate CPPD crystal 
formation. 
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Introduction 
Calcium pyrophosphate dihydrate (CPPD) crystal 
deposition disease is characterized by CPPD crystal deposits 
in articular and fibrocartilage, especially knee menisci [26] . 
To date, there is no way to halt the progressive deposition of 
CPPD crystals nor is there a clinically suitable method of 
removing those already deposited [26]. The pathogenesis of 
cartilage degeneration in this arthritic disease is thought to 
include an amplification loop [12] ; damaged cartilage is 
predisposed to CPPD crystal deposition which then induces 
further enzymatic or mechanical damage to the cartilage . In 
familial CPPD crystal deposition disease, changes have been 
noted in the cartilagenous matrix which antedate the formation 
of CPPD crystals [4] . CPPD crystals induce both 
synoviocytes [ JO] and chondrocytes [ 11] in cell culture to 
release collagenase and neutral protease. This self-
perpetuating loop could explain many of the clinical 
observations seen in patients with CPPD crystal deposition 
disease. 
The initial deposits of CPPD appear to be located at 
the lacunar margins of degenerating chondrocytes in areas of 
reduced safranin O staining, indicative of reduced acid 
mucopolysaccharide concentrations [ 15], whereas larger 
deposits are associated with cellular necrosi s in the periphery 
[3]. CPPD deposits have also been observed on collagen 
bundles [2]. Although some crystals occur in areas of 
degeneration, others are found in cartilage possessing normal 
histology . The apparent in vivo preference of CPPD crystals 
for collagen denuded of proteoglycan suggests that the native 
collagen fibrils (or their accompanying macromolecules) may 
serve as nucleating templates for crystal formation. 
The mechanism of CPPD crystal deposition in 
cartilage is not understood, in part because CPPD deposition 
apparently occurs in an undersaturated environment. There 
does not appear to be any gross disturbance in the systemic 
metabolism of inorganic pyrophosphate (PPi) in patients with 
CPPD crystal deposition disease [25]. Even in the elevated 
state, the [Ca] and [PPi] in the synovial fluid are 
undersaturated [l]. Thus, the need for an in vitro model for 
CPPD crystal deposition has long been recognized . 
Although almost 30 different Ca and mixed Ca 
pyrophosphates have been synthesized [16], only two distinct 
crystallographic dimorphs of CPPD have been observed in 
vivo: triclinic (t) and monoclinic (m) CPPD . In menisci, 
which is the most common crystal deposition site [l], t-
CPPD predominates in a ratio of 3:1 [21]. Since in vitro 
preparations of t-CPPD and m-CPPD necessitate a pH of 3.0 
and high concentrations of Ca and PPi [20], solution studies 
modeling CPPD deposition have attempted to determine the 
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[Ca] and [PPi] necessary for crystal nucleation and growth at 
physiologic pH [7, 8, 9, 14]. 
CPPD crystal growth has also been modeled using 
biological grade gelatin [23], silica gel [23], polyacrylamide 
gel [13], and whole cartilage [24], however none of these 
models were able to reproduce t-CPPD and m-CPPD crystal 
growth at physiologic conditions. We successfully grew t-
CPPD and m-CPPD at physiologic ionic concentrations using 
biological grade gelatin in an ionic diffusion model [18, 19]. 
However, other crystalline species were also formed and both 
t-CPPD and m-CPPD grew in non-phy siologically observed 
crystal growth habits, i.e . as long needles . These studies 
did, however, indicate that the time of incubation of Ca and 
PPi ions was a critical parameter in determining the type of 
crystal formed, and that the formation of the two in vivo 
crystals was mediated by the formation of intermediate 
crystalline materials and the subsequent dissolution of those 
species. The formation/dissolution/reformation mechanism 
allowed for a very localized ionic concentrating process to 
occur. 
Although the biological grade gelatin system allowed 
for a much better understanding of the possible kinetics of 
CaPPi crystal growth, the question arises as to whether native 
collagen fibrils act differently than the denatured form of 
collagen in mediating the crystal growth process . Therefore, 
we investigated the effect of type I collagen fibrils on CPPD 
crystal nucleation and growth using our ionic diffusion 
model. 
Materials and Methods 
Collagen purification 
Type I collagen was isolated from porcine meniscus 
using a pepsin solubilization procedure [22]. Briefly, the 
menisci were dissected from the knee joints within 24 hours 
of slaughter of 4 to 6 month old pigs (Patrick Cudhay, 
Cudhay , WI) . Standard surgical procedures were used to 
separate the medial and lateral menisci from each joint. The 
menisci were trimmed of surrounding fat, ligaments, and the 
opalescent anterior edge which is composed of both type I 
and II collagens . The menisci were thinly sliced, rinsed with 
a 0.9% saline solution at 4 °C, and freeze milled (Spex 
Industries, Metuchin, NJ) for a short time. In order to extract 
the proteoglycan prior to the collagen isolation procedure, 
cartilage fragments were then extracted twice with 20 
volumes to weight of 4 M guanidine, 0.05 M Tris-HCl at pH 
7.4 at 4 °C for 48 hours . Centrifugation between extractions 
was carried out at 30,000 x g. The precipitated fragments 
were then stirred for 15 hours at 4 °Cina sufficient volume 
of cold 0.5 M acetic acid containing 1 mg/ml pepsin to 
maintain a collagen to pepsin ratio of 10: I. The suspension 
was centrifuged at 35,000 x g for I hour at 4 °C. The 
extraction procedure was repeated, and the supernatants 
pooled. The soluble collagen was precipitated by the addition 
of sufficient crystalline NaCl to give a final concentration of 
2.0 M and then collected by centrifugation at 35,000 x g for 2 
hours at 4 °C. The precipitated type I collagen was then 
redissolved in 1.0 M NaCl, 0.05 M Tris-HCI at pH 7.5 and 
dialyzed overnight against this same solution . Any 
precipitated material was removed by centrifugation at 35,000 
x g and discarded . The type I collagen was again precipitated 
overnight by the addition of crystalline NaCl to a final 
concentration of 4.0 M. Then, the solution was centrifuged 
for 2 hours at 35,000 x g, redissolved in 0.5 M acetic acid, 
dialyzed against 0.05 M acetic acid and then lyophilized . 




The gels were prepared as 3 layers in glass tubes (8 
mm i.d. x 100 mm, total volume 5 ml) . The ends of the 
tubes were stoppered with serum caps . Three collagen 
solutions were prepared in 0.05 M Hepes buffer (pH 7.4) at a 
concentration of 2.5 mg/ml . The bottom layer consisted of I 
ml of the Ca solution (25 mM CaCl2, 78 mM NaCl, 4.5 mM 
KC!, 1.0 mM MgSO4), the middle layer consisted of 2 ml of 
only the secondary ions (128 mM NaCl, 4.5 mM KC!, 1.0 
mM MgSO4,), and the top layer consisted of 1 ml of the PPi 
solution (10 mM N~P2O7, 88 mM NaCl, 4.5 mM KC!, 1.0 
mM MgSO4) . Sodium azide (15 mM) was included in all 
layers to prevent fungal growth . The solutions were layered 
separately while cold and incubated at 37° C to gel before the 
next layer was poured. The total length of the gel was 8 cm. 
The gel tubes were prepared in triplicate, incubated at 
37° C, and harvested at 14 preset times over a 6 month 
period. In order to facilitate their handling at harvest, the gel 
tubes were immersed in an acetone-dry ice bath for 20 
seconds. This short cold treatment kept the collagen gels 
from melting while they were being separated but did not 
induce any crystal growth. The gel was then pushed from_ the 
tube in 1 cm increments which were sliced off and placed mto 
clean tubes for the analyses described below. 
Crystal Characterization 
The collagen gels were allowed to melt at room 
temperature and the crystalline material was isolated by 
centrifugation, washed twice with doubly distilled water, and 
air-dried. The supematants from the gels were saved for Ca 
and PPi analyses as described below. All crystalline samples 
were characterized using copper radiation generated by a 12 
kW high brilliance rotating anode x-ray generator (Rigaku, 
Japan) . Samples were diffracted using a germanium crystal 
monochromated Guinier powder diffraction camera (Huber 
Instruments, West Germany). Diffraction patterns were 
compared to those of known pyrophosphate structures [16]. 
The term amorphous calcium pyrophosphate (a or a-CaPPi) 
was operationally defined as the presence of a significant 
amount of precipitate with a diffraction pattern containing a 
broad diffu se background but with no distinct diffraction 
lines. Representative samples were characterized further with 
scanning electron microscopy (Model 1200, Advanced Metals 
Research Corp. , Bedford, MA) . 
Pyrophosphate assay 
Pyrophosphate determination s were_ carried out ?Y 
using the assay kit (P-7275, Sigma Chemical, St. Louis , 
MO). Aliquots of the meniscus gel were diluted 1: 10 bef<?re 
analyses. In addition to determini_ng the [PPi] at each pom~ 
within the gel , we also determined the amount of PPi 
hydrolysis which had occurred as the experiment progressed 
by assaying the PPi level in standard collagen gel tubes , 
which contained only the PPi solution and were prepared at 
the beginning of the experiment. Hydrolysis was not a 
significant problem. 
Calcium assay 
Calcium was determined by atomic absorption 
analysis (Model AA-1475, Varian As_sociates_, Palo A~to, 
CA). A 0.30 ml aliquot of the gel was diluted with a solution 
containing 1 % LaCl3 in 5% HCl according to standard 
procedures. Concentrations were determined using a 1000 
µg/ml Ca standard in 2% HCl (Fisher Scientific, Itasca, IL) 
diluted as above. 
Preparation of Ion Gradient Contour Plots 
The [Ca] was plotted as a function of tube position 
and time. Contours were drawn at levels of 1 mM up to 10 
mM, after which they were contoured at 5 mM intervals. The 
[PPi] contour plot was constructed in the same manner, 
except that the contour levels were 0.025, 0.05, 0.10, 0.25, 
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0.50, 0.75, 1.0 mM and then at 1 mM increments up to 10 
mM, and the two plots superimposed photographically . The 
crystals which had been identified at each tube position and 
time point were then added to the composite ionic gradient 
plot. 
Results 
Figure 1 shows the ionic gradient plots of the [Ca] 
and [PPi] and the crystals formed in the gels. A diffuse 
amorphous band in the center of the gel was observed in 2 
days which corresponded to the Ca/PPi ionic interface. 
Amorphous CaPPi formed when [Ca] was between 1 and 3 
mM and when [PPi] was between 0.1 and I mM . This 
diffuse band spread throughout the tube within 2 weeks, after 
which time the [Ca] and [PPi] fell to physiologic levels . 
At 3 to 4 months , most of the diffuse band had 
disappeared, leaving a clear gel which contained large clumps 
of crystals which were identified as t-CPPD and m-CPPD . 
Monoclinic CPPD crystallized .first in 6 weeks when the [Ca] 
was 2 mM and the [PPi] was between 50 and 75 µM . 
Triclinic CPPD first formed at 13 weeks when the [Ca] was 
also 2 mM, but the [PPi] was less than 25 µM . As shown in 
Figure 2, the t-CPPD crystals which were isolated at 15 
weeks had the very distinctive prismatic growth morphology, 
while the crystal growth habit of m-CPPD was rod shaped. 
There were numerous t-CPPD and m-CPPD crystals seen in 
the sample view ed and no other growth habits were 
observed . The primary crystal growth faces of t-CPPD are 
the { 100), the {011}, and the (001} [16,17], while those of 
m-CPPD are the { 100), the {010), and the {001} [16]. 
Djscyssjon 
Previous solution studies have shown that, although 
other calcium pyrophosphates would grow at physiologic 
ionic concentrations, t-CPPD and m-CPPD would not. 
Heam and Russell [14] found by optical microscopy that at 
physiologic [Ca] and [PPi], the first species to form were an 
amorphous material when physiologic [Mg] was present and 
orthorhombic calcium pyroph osphate tetrahydrate (o-CPPT) 
when there was no Mg. Cheng and Pritzker [7] found that 
for t-CPPD and m-CPPD crystal formation in solution, the 
PPi concentration must be greater than 1 mM and 3.2 mM, 
respectively. The mean PPi level in normal synovial fluid is 
3 µM [26] and 10 µM in patient s with CPPD crystal 
deposition disease [27]. At physiologic levels of magnesium 
and phosphate, a-CaPPi formed, but neither t-CPPD norm-
CPPD would form (7, 8]. 
In our previous biological grade gelatin gels [ 18, 19], 
the diffuse band at the Ca/PPi interface was present at early 
times and always tran sformed from a-CaPPi to o-CPPT 
within the first few days of incubation . In contrast , in this 
study using meniscus collagen gel, thi s band remained 
amorphous throughout the entire experiment. Similar to the 
biological grade gelatin studies, m-CPPD was identified 
earlier than t-CPPD . 
One of the most striking differences between this 
system and previous solution and gel model systems is the 
total absence of o-CPPT from the native collagen gels as 
compared to all the other model studies . Further , crystal 
morphology is more sensitive to subtle changes in the 
crystallization conditions than is crystal form . Using the 
native type collagen gels (Figure 2), crystals of t-CPPD 
appear as large single crystals with the classic prismatic 
growth habit observed in vivo [6], and crystals of m-CPPD 
177 
Figure 1: The kinetic map of CPPD crystallization in pepsin 
solubilized porcine meniscus type I collagen gels. The [Ca] 
and [PPi] ionic gradients have been contoured as a function 
of time and tube position and have been overlayed with the 
crystal types observed. The [Ca] has been contoured with 
dashed lines and the [PPi] is denoted with solid lines. The 
[Ca] has been contoured at 1 mM levels below 10 mM and at 
5 mM levels above 10 mM. The [PPi] has been contoured at 
0.025, 0.05, 0.075, 0.10, 0.25, 0.50, 0.75, 1.0 mM and 
then at 1 mM increments up to 10 mM. Tubes were prepared 
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Figure 2: A scanning electron micrograph showing the 
prismatic crystal growth habit of t-CPPD crystals (large 
arrow) and the rod crystal growth habit of m-CPPD crystals 
(small arrows) observed in layer 3 after 15 weeks of 
incubation. These crystal growth morphologies are identical 
to those observed in vivo. Bar is 25 µm. 
have the classic rod habit. In contrast, the crystal growth 
habits of t-CPPD, m-CPPD, and o-CPPT grown in biological 
gelatin model systems were always needles [18, 19]. 
The ionic diffusion in collagen model system 
described in this study appears to be the most reasonable 
model system to date in that it has produced only crystals of 
a-CaPPi, t-CPPD and m-CPPD . Although the pepsin 
solubilizing procedure removes the telopeptides from the 
collagen molecules, it maintains near native conformation of 
the collagen fibrils themselves . The crystals were grown in 
the most nearly physiologic environment of all the model 
systems. Finally, the crystal growth habits of both t-CPPD 
and m-CPPD grown in the native collagen gel system match 
those observed in vivo. When compared to the previous 
studies , these results, particularly the crystal growth habit 
data, would seem to indicate that the native collagen fibrils 
themselves can nucleate CPPD crystal formation . 
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Discussion with Reviewers 
K,P,H, Pritzker; This paper describes the formation of 
m-CPPD and t-CPPD in an in vitro collagen gel system . 
Although the system is different , the results appear to be 
substantially similar to those recently published (Hunter GK, 
Grynpas MD, Cheng P-T, Pritzker KPH (1987) Effect of 
glycosaminoglycans on calcium pyrophosphate crystal 
formation in collagen gels. Calcif Tissue Int il, 164-170). 
Authors; We disagree that these are similar to those of 
Hunter, et. al. First, their experiments were conducted at a 
Ca:P ratio of 2: 1, rather than at the physiological ratio which 
is in the range of 150:1. The [Ca] and [PPi] which we have 
investigated in this study not only covered physiological 
ratios, but also included physiological concentrations. 
Hunter , et.al. did not publish the crystallographic 
identification of the crystalline precipitates formed in their 
study. Using the three x-ray diffraction patterns which they 
published instead, we have determined that the crystals that 
they grew at 1.6 mM Ca and 0.8 mM PPi were, in fact, pure 
o-CPPT. Also, based on their published patterns, an 
unknown calcium pyrophosphate crystal was the sole 
crystalline product formed both at 1.6 mM Ca, 0.8 mM PPi, 
0.32 mM Mg and at 40 mM Ca, 25 mM PPi, 8 mM Mg. We 
have previously reported and characterized this same 
unknown calcium pyrophosphate crystal, labelling it as 
Unknown B [19] . Using energy dispersive x-ray 
microanalysis , we found that this crystalline unknown has an 
atomic ratio of 0.69:0.08: 1.0 for Ca:Na:P. 
Finally, Hunter, et. al. described the crystal growth 
habit as "spherical clusters of needle-shaped crystals". Thus, 
their results form a very striking contrast to those presented 
here. There are two possible explanations for the differences 
in the results between their study and ours even though both 
experiments were conducted with type I collagen in near-
native fibril conformation . One is the differences in 
experimental conditions and set-ups. Their super physiologic 
ionic concentration and Ca :PPi ratios has already been 
discussed. Another experimental difference is in the 
geometry of the diffusion . In their system, high PPi 
concentrations were incorporated into a collagen gel and a 
solution containing high Ca concentrations was layered 
directly on top of the gel. Another possible contributing 
factor accounting for these differences may be related to 
differences in the conformation of collagen isolated from rat 
179 
tails by acid solub ilization versus the conformation of 
collagen isolated from fibrocartilage by pepsin solubilization. 
K,P,H, Prjtzker; The authors suggest that type I collagen 
nucleates crystal formation. The evidence for this inference is 
not clear. It is possible to grow t-CPPD and m-CPPD in 
solution and gels by other methods . In these systems, the 
CPPD crystals can have similar morphology to in vivo 
crystals . 
Authors; We agree that the evidence which suggests that 
type I collagen nucleates CPPD crystal formation is primarily 
negative, i.e. it is based on the absence of a result rather the 
presence of concrete data . However, it is a very compelling 
argument when all the data are reviewed together . It is 
significant that only t-CPPD, m-CPPD, and a-CaPPi were 
formed by ionic diffusion of physiological levels of Ca and 
PPi in the presence of type I collagen, while other non-
physiologic calcium pyrophosphates were identified in all of 
the other previous crystal growth experiments . This fact, 
coupled with the fact that the characteristic crystal growth 
habits of t-CPPD and m-CPPD only have been observed in 
this study and in no other studies, has formed the basis for 
this inference . We are currently conducting experiments to 
characterize and quantitate the possible nucleating potential of 
type I collagen in a more positive way. 
R, Terkeltaub: Is there any difference from the results in 
Figure 1 when different procedures are used to isolate type I 
collagen from porcine meniscus? 
Authors; There is no other way to isolate type I collagen 
from meniscus. The more gentle isolation procedures used to 
isolate type I collagen from rat tails will not yield any collagen 
when applied to cartilagenou s tissues. However, we are 
currently investigating the difference s in CPPD crystal 
growth in gels made of pepsin solubilized meniscus collagen 
and acid solubilized rat tail collagen. 
R, Tawashj: The fact that different faces of the m-CPPD 
and t-CPPD crystals are developed in the native collagen fibril 
gel system suggests that the structure of collagen fibrils as 
well as the presence of other impurities (e.g. sodium azide) 
are responsible for the direction of growth. I wonder how 
the growth process will proceed in the absence of 15 mM 
sodium azide, if growth was conducted under asceptic 
conditions. 
Authors; All of the gel studies conducted in references 18 
and 19 were also conducted in the presence of sodium azide. 
The only previously published report on the formation of t-
CPPD and m-CPPD at physiologic levels of calcium and 
pyrophosphate was in one of our previous ionic diffusion 
experiments using biological gelatin [18]. In this experiment, 
the sodium azide concentration was 30 mM . This sample of 
t-CPPD and m-CPPD also contained o-CPPT. In the 
biological gelatin experiment, the crystal growth habits of all 
three crystals were indistinguishable from each other, as they 
all grew either as needles and as clumps of needles radiating 
from a single point. 
R, TerkeUaub: Have you evaluated collagen isolated from 
animals with experimental degenerative joint disease? What 
are the effects of proteolytic collagen peptides or synthetic 
collagen oligopeptides on CPPD crystal nucleation in this 
model? Can proteoglycans native to articular cartilage or the 
extent of proteoglycan polymerization influence CPPD crystal 
nucleation in this model? 
Authors; All of these questions are very important to our 
understanding of the pathogenesis of CPPD crystal 
deposition disease . Currently, we are investigating the 
possibility that it is the method of collagen extraction, i.e. the 
Gretchen S. Mandel*, Paul B. Halverson, Melisa Rathburn, and Neil S. Mandel 
nature of the collagen degradation, which may play a role in 
the apparent potential for type I collagen to nucleate CPPD 
crystals. These other questions will be addressed in future 
studies. 
180 
